Management of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization

被引：100
作者：
Pasi, KJ
Collins, PW
Keeling, DM
Brown, SA
Cumming, AM
Dolan, GC
Hay, CRM
Hill, FGH
Laffan, M
Peake, IR
机构：
[1] Barts & London, Queen Marys Sch Med Dent, Dept Haematol, UKHCDO von Willebrand Dis Working Party, London E1 2AD, England
[2] Univ Wales Hosp, Arthur Bloom Haemophilia Ctr, Cardiff CF4 4XW, S Glam, Wales
[3] Churchill Hosp, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England
[4] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
[5] Manchester Royal Infirm, Univ Dept Haematol, Manchester M13 9WL, Lancs, England
[6] Queens Med Ctr, Dept Haematol, Nottingham NG7 2UH, England
[7] Childrens Hosp, Dept Haematol, Birmingham B16 8ET, W Midlands, England
[8] Hammersmith Hosp, Imperial Coll, Dept Haematol, London, England
[9] Univ Sheffield, Div Genom Med, Sheffield, S Yorkshire, England
来源：
HAEMOPHILIA | 2004年 / 10卷 / 03期
关键词：
blood products; 1-deamino-8-D-arginine vasopressin; guideline; inherited bleeding disorder; treatment; von Willebrand disease;
D O I：
10.1111/j.1365-2516.2004.00886.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
von Willebrand disease (VWD) is the commonest inherited bleeding disorder. The aim of therapy for VWD is to correct the two defects of haemostasis in this disorder, impaired primary haemostasis because of defective platelet adhesion and aggregation and impaired coagulation as a result of low levels of factor VIII. The objective of this guideline is to inform individuals making choices about the treatment and management of VWD including the use of therapeutic products. This is the second edition of this UK Haemophilia Centre Doctors' Organization (UKHCDO) guideline and supersedes the previous edition which was published in 1994.
引用
收藏
页码：218 / 231
页数：14
相关论文
共 76 条
[61]  
Ong YL, 1998, HAEMOPHILIA, V4, P63
[62]   Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract [J].
Orsi, P ;
Guatti-Zuliani, C ;
Okolicsanyi, L .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (04) :330-334
[63]   CLINICAL AND LABORATORY EVALUATION OF THE TREATMENT OF VONWILLEBRANDS DISEASE PATIENTS WITH HEAT-TREATED FACTOR-VIII CONCENTRATE (BPL-8Y) [J].
PASI, KJ ;
WILLIAMS, MD ;
ENAYAT, MS ;
HILL, FGH .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (02) :228-233
[64]   COMPARATIVE-STUDY OF TRANEXAMIC ACID AND NORETHISTERONE IN THE TREATMENT OF OVULATORY MENORRHAGIA [J].
PRESTON, JT ;
CAMERON, IT ;
ADAMS, EJ ;
SMITH, SK .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (05) :401-406
[65]  
RAMSAY DM, 1976, LANCET, V2, P275
[66]  
Ray J G, 1998, Obstet Gynecol Surv, V53, P450, DOI 10.1097/00006254-199807000-00025
[67]  
Rodeghiero F, 1996, THROMB HAEMOSTASIS, V76, P692
[68]  
SADLER JE, 1994, THROMB HAEMOSTASIS, V71, P520
[69]  
SCHARRER I, 1994, HAEMOSTASIS, V24, P298
[70]  
SINDETPEDERSEN S, 1991, DAN MED BULL, V38, P427
12345678